These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37378020)

  • 41. The influence of aging on the diagnosis of primary aldosteronism.
    Nakama C; Kamide K; Kawai T; Hongyo K; Ito N; Onishi M; Takeya Y; Yamamoto K; Sugimoto K; Rakugi H
    Hypertens Res; 2014 Dec; 37(12):1062-7. PubMed ID: 25164207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
    Zhang D; Chen T; Tian H; Li Y; Mo D; Zhang T; Wang W; Zhang G; Liu Y; Tang L; Zhu Y; Yang L; Ren Y
    Endocr Pract; 2020 Aug; 26(8):891-899. PubMed ID: 33471680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension.
    Iwaoka T; Umeda T; Naomi S; Inoue J; Sasaki M; Yamauchi J; Sato T
    Am J Hypertens; 1993 Nov; 6(11 Pt 1):899-906. PubMed ID: 8305162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
    Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
    J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
    Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional tests for primary aldosteronism: value of captopril suppression.
    Racine MC; Douville P; Lebel M
    Curr Hypertens Rep; 2002 Jun; 4(3):245-9. PubMed ID: 12003708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
    Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
    Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.
    Kita T; Furukoji E; Sakae T; Kitamura K
    Hypertens Res; 2019 Jun; 42(6):801-806. PubMed ID: 30622316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism.
    Wang K; Hu J; Yang J; Song Y; Fuller PJ; Hashimura H; He W; Feng Z; Cheng Q; Du Z; Wang Z; Ma L; Yang S; Li Q
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32449927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.
    Tsiavos V; Markou A; Papanastasiou L; Kounadi T; Androulakis II; Voulgaris N; Zachaki A; Kassi E; Kaltsas G; Chrousos GP; Piaditis GP
    Eur J Endocrinol; 2016 Jul; 175(1):21-8. PubMed ID: 27072145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
    Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of aldosterone/direct renin ratio before drug washout in the screening of primary aldosteronism].
    Ma WJ; Lou Y; Bian J; Cai J; Zhang HM; Zhou XL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(41):3250-3254. PubMed ID: 33167113
    [No Abstract]   [Full Text] [Related]  

  • 57. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
    Tezuka Y; Turcu AF
    Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.
    Li T; Ma Y; Zhang Y; Liu Y; Fu T; Zhang R; Kang K; Yang Y; Wang L; Jiang Y; Lu Y
    Int J Hypertens; 2019; 2019():2195796. PubMed ID: 31354984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
    Dorrian CA; Toole BJ; Alvarez-Madrazo S; Kelly A; Connell JM; Wallace AM
    Ann Clin Biochem; 2010 May; 47(Pt 3):195-9. PubMed ID: 20392751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.